Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.

Martinez-Garcia E, Lesur A, Devis L, Cabrera S, Matias-Guiu X, Hirschfeld M, Asberger J, van Oostrum J, Casares de Cal MLÁ, Gómez-Tato A, Reventos J, Domon B, Colas E, Gil-Moreno A.

Clin Cancer Res. 2017 Nov 1;23(21):6458-6467. doi: 10.1158/1078-0432.CCR-17-0474. Epub 2017 Aug 8.

2.

An "on-matrix" digestion procedure for AP-MS experiments dissects the interplay between complex-conserved and serotype-specific reactivities in Dengue virus-human plasma interactome.

Ramos Y, Huerta V, Martín D, Palomares S, Yero A, Pupo D, Gallien S, Martín AM, Pérez-Riverol Y, Sarría M, Guirola O, Chinea G, Domon B, González LJ.

J Proteomics. 2019 Feb 20;193:71-84. doi: 10.1016/j.jprot.2017.07.004. Epub 2017 Jul 13.

PMID:
28713027
3.

Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine.

Duriez E, Masselon CD, Mesmin C, Court M, Demeure K, Allory Y, Malats N, Matondo M, Radvanyi F, Garin J, Domon B.

J Proteome Res. 2017 Apr 7;16(4):1617-1631. doi: 10.1021/acs.jproteome.6b00979. Epub 2017 Mar 23.

PMID:
28287737
4.

New Guidelines for Publication of Manuscripts Describing Development and Application of Targeted Mass Spectrometry Measurements of Peptides and Proteins.

Abbatiello S, Ackermann BL, Borchers C, Bradshaw RA, Carr SA, Chalkley R, Choi M, Deutsch E, Domon B, Hoofnagle AN, Keshishian H, Kuhn E, Liebler DC, MacCoss M, MacLean B, Mani DR, Neubert H, Smith D, Vitek O, Zimmerman L.

Mol Cell Proteomics. 2017 Mar;16(3):327-328. doi: 10.1074/mcp.E117.067801. Epub 2017 Feb 9. No abstract available.

5.

Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.

Martinez-Garcia E, Lesur A, Devis L, Campos A, Cabrera S, van Oostrum J, Matias-Guiu X, Gil-Moreno A, Reventos J, Colas E, Domon B.

Oncotarget. 2016 Aug 16;7(33):53102-53115. doi: 10.18632/oncotarget.10632.

6.

Parallel reaction monitoring using quadrupole-Orbitrap mass spectrometer: Principle and applications.

Bourmaud A, Gallien S, Domon B.

Proteomics. 2016 Aug;16(15-16):2146-59. doi: 10.1002/pmic.201500543. Epub 2016 May 27. Review.

PMID:
27145088
7.

Dataset on protein composition of a human plasma sub-proteome able to modulate the Dengue 2 virus infection in Huh 7.5 cells.

Huerta V, Ramos Y, Yero A, Pupo D, Martin D, Márquez G, Martín A, Sarría M, Gallien S, González LJ, Domon B, Chinea G.

Data Brief. 2015 Dec 17;6:352-8. doi: 10.1016/j.dib.2015.12.016. eCollection 2016 Mar.

8.

Complexity reduction of clinical samples for routine mass spectrometric analysis.

Mesmin C, van Oostrum J, Domon B.

Proteomics Clin Appl. 2016 Apr;10(4):315-22. doi: 10.1002/prca.201500135. Epub 2016 Jan 22. Review.

PMID:
26680238
9.

The use of proteases complementary to trypsin to probe isoforms and modifications.

Trevisiol S, Ayoub D, Lesur A, Ancheva L, Gallien S, Domon B.

Proteomics. 2016 Mar;16(5):715-28. doi: 10.1002/pmic.201500379. Review.

PMID:
26663565
10.

Novel interactions of domain III from the envelope glycoprotein of dengue 2 virus with human plasma proteins.

Huerta V, Ramos Y, Yero A, Pupo D, Martín D, Toledo P, Fleitas N, Gallien S, Martín AM, Márquez GJ, Pérez-Riverol Y, Sarría M, Guirola O, González LJ, Domon B, Chinea G.

J Proteomics. 2016 Jan 10;131:205-213. doi: 10.1016/j.jprot.2015.11.003. Epub 2015 Nov 3.

PMID:
26546555
11.

Structural characterization and biological implications of sulfated N-glycans in a serine protease from the neotropical moth Hylesia metabus (Cramer [1775]) (Lepidoptera: Saturniidae).

Cabrera G, Salazar V, Montesino R, Támbara Y, Struwe WB, Leon E, Harvey DJ, Lesur A, Rincón M, Domon B, Méndez M, Portela M, González-Hernández A, Triguero A, Durán R, Lundberg U, Vonasek E, González LJ.

Glycobiology. 2016 Mar;26(3):230-50. doi: 10.1093/glycob/cwv096. Epub 2015 Nov 3.

PMID:
26537504
12.

Longitudinal Urinary Protein Variability in Participants of the Space Flight Simulation Program.

Khristenko NA, Larina IM, Domon B.

J Proteome Res. 2016 Jan 4;15(1):114-24. doi: 10.1021/acs.jproteome.5b00594. Epub 2015 Dec 3.

PMID:
26517171
13.

Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM).

Demeure K, Fack F, Duriez E, Tiemann K, Bernard A, Golebiewska A, Bougnaud S, Bjerkvig R, Domon B, Niclou SP.

Mol Cell Proteomics. 2016 Feb;15(2):481-92. doi: 10.1074/mcp.M115.052423. Epub 2015 Aug 4.

14.

Advances in high-resolution quantitative proteomics: implications for clinical applications.

Gallien S, Domon B.

Expert Rev Proteomics. 2015;12(5):489-98. doi: 10.1586/14789450.2015.1069188. Epub 2015 Jul 18. Review.

PMID:
26189960
15.

Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype-specific PRM assays.

Kim YJ, Gallien S, El-Khoury V, Goswami P, Sertamo K, Schlesser M, Berchem G, Domon B.

Proteomics. 2015 Sep;15(18):3116-25. doi: 10.1002/pmic.201400382. Epub 2015 Aug 17.

PMID:
26177823
16.

Detection and quantification of proteins in clinical samples using high resolution mass spectrometry.

Gallien S, Domon B.

Methods. 2015 Jun 15;81:15-23. doi: 10.1016/j.ymeth.2015.03.015. Epub 2015 Apr 2.

PMID:
25843604
17.

Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM).

Gallien S, Kim SY, Domon B.

Mol Cell Proteomics. 2015 Jun;14(6):1630-44. doi: 10.1074/mcp.O114.043968. Epub 2015 Mar 9.

18.

Screening protein isoforms predictive for cancer using immunoaffinity capture and fast LC-MS in PRM mode.

Lesur A, Ancheva L, Kim YJ, Berchem G, van Oostrum J, Domon B.

Proteomics Clin Appl. 2015 Aug;9(7-8):695-705. doi: 10.1002/prca.201400158. Epub 2015 Mar 30.

PMID:
25656350
19.

Verification of the biomarker candidates for non-small-cell lung cancer using a targeted proteomics approach.

Kim YJ, Sertamo K, Pierrard MA, Mesmin C, Kim SY, Schlesser M, Berchem G, Domon B.

J Proteome Res. 2015 Mar 6;14(3):1412-9. doi: 10.1021/pr5010828. Epub 2015 Feb 9.

PMID:
25597550
20.

Advances in high-resolution accurate mass spectrometry application to targeted proteomics.

Lesur A, Domon B.

Proteomics. 2015 Mar;15(5-6):880-90. doi: 10.1002/pmic.201400450. Epub 2015 Feb 10. Review.

PMID:
25546610
21.

Recent advances in targeted proteomics for clinical applications.

Domon B, Gallien S.

Proteomics Clin Appl. 2015 Apr;9(3-4):423-31. doi: 10.1002/prca.201400136. Epub 2015 Feb 19. Review.

PMID:
25504492
22.

Protein quantification using a cleavable reporter peptide.

Duriez E, Trevisiol S, Domon B.

J Proteome Res. 2015 Feb 6;14(2):728-37. doi: 10.1021/pr500764e. Epub 2014 Dec 3.

PMID:
25411902
23.

Quantification of proteins in urine samples using targeted mass spectrometry methods.

Khristenko N, Domon B.

Methods Mol Biol. 2015;1243:207-20. doi: 10.1007/978-1-4939-1872-0_12.

PMID:
25384748
24.

Quantitative proteomics using the high resolution accurate mass capabilities of the quadrupole-orbitrap mass spectrometer.

Gallien S, Domon B.

Bioanalysis. 2014 Aug;6(16):2159-70. doi: 10.4155/bio.14.115.

PMID:
25331860
25.

Improvement of the performance of targeted LC-MS assays through enrichment of histidine-containing peptides.

Mesmin C, Domon B.

J Proteome Res. 2014 Dec 5;13(12):6160-8. doi: 10.1021/pr5008152. Epub 2014 Oct 31.

PMID:
25321649
26.

PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species.

Demeure K, Duriez E, Domon B, Niclou SP.

Front Genet. 2014 Sep 2;5:305. doi: 10.3389/fgene.2014.00305. eCollection 2014.

27.

A simple protocol to routinely assess the uniformity of proteomics analyses.

Gallien S, Bourmaud A, Domon B.

J Proteome Res. 2014 May 2;13(5):2688-95. doi: 10.1021/pr4011712. Epub 2014 Apr 14.

PMID:
24617767
28.

Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.

Carr SA, Abbatiello SE, Ackermann BL, Borchers C, Domon B, Deutsch EW, Grant RP, Hoofnagle AN, Hüttenhain R, Koomen JM, Liebler DC, Liu T, MacLean B, Mani DR, Mansfield E, Neubert H, Paulovich AG, Reiter L, Vitek O, Aebersold R, Anderson L, Bethem R, Blonder J, Boja E, Botelho J, Boyne M, Bradshaw RA, Burlingame AL, Chan D, Keshishian H, Kuhn E, Kinsinger C, Lee JS, Lee SW, Moritz R, Oses-Prieto J, Rifai N, Ritchie J, Rodriguez H, Srinivas PR, Townsend RR, Van Eyk J, Whiteley G, Wiita A, Weintraub S.

Mol Cell Proteomics. 2014 Mar;13(3):907-17. doi: 10.1074/mcp.M113.036095. Epub 2014 Jan 17.

29.

Characterization of protein complexes using targeted proteomics.

Gomez YR, Gallien S, Huerta V, van Oostrum J, Domon B, Gonzalez LJ.

Curr Top Med Chem. 2014;14(3):344-50. Review.

PMID:
24304311
30.

Technical considerations for large-scale parallel reaction monitoring analysis.

Gallien S, Bourmaud A, Kim SY, Domon B.

J Proteomics. 2014 Apr 4;100:147-59. doi: 10.1016/j.jprot.2013.10.029. Epub 2013 Nov 4.

PMID:
24200835
31.

Targeted proteomics strategy applied to biomarker evaluation.

Kim YJ, Gallien S, van Oostrum J, Domon B.

Proteomics Clin Appl. 2013 Dec;7(11-12):739-47. doi: 10.1002/prca.201300070. Epub 2013 Oct 31.

PMID:
24123942
32.

Selectivity of LC-MS/MS analysis: implication for proteomics experiments.

Gallien S, Duriez E, Demeure K, Domon B.

J Proteomics. 2013 Apr 9;81:148-58. doi: 10.1016/j.jprot.2012.11.005. Epub 2012 Nov 14.

PMID:
23159602
33.

Considerations on selected reaction monitoring experiments: implications for the selectivity and accuracy of measurements.

Domon B.

Proteomics Clin Appl. 2012 Dec;6(11-12):609-14. doi: 10.1002/prca.201200111. Review.

PMID:
23112131
34.

Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer.

Gallien S, Duriez E, Crone C, Kellmann M, Moehring T, Domon B.

Mol Cell Proteomics. 2012 Dec;11(12):1709-23. doi: 10.1074/mcp.O112.019802. Epub 2012 Sep 7.

35.

Peptides quantification by liquid chromatography with matrix-assisted laser desorption/ionization and selected reaction monitoring detection.

Lesur A, Varesio E, Domon B, Hopfgartner G.

J Proteome Res. 2012 Oct 5;11(10):4972-82. doi: 10.1021/pr300514u. Epub 2012 Aug 31.

PMID:
22897511
36.

Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.

Musante L, Saraswat M, Duriez E, Byrne B, Ravidà A, Domon B, Holthofer H.

PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.

37.

Highly multiplexed targeted proteomics using precise control of peptide retention time.

Gallien S, Peterman S, Kiyonami R, Souady J, Duriez E, Schoen A, Domon B.

Proteomics. 2012 Apr;12(8):1122-33. doi: 10.1002/pmic.201100533.

PMID:
22577013
38.

Mass spectrometry-based detection and quantification of plasma glycoproteins using selective reaction monitoring.

Kim YJ, Zaidi-Ainouch Z, Gallien S, Domon B.

Nat Protoc. 2012 Apr 12;7(5):859-71. doi: 10.1038/nprot.2012.023.

PMID:
22498706
39.

Lung cancer statistics in Luxembourg from 1981 to 2008.

Thill PG, Goswami P, Berchem G, Domon B.

Bull Soc Sci Med Grand Duche Luxemb. 2011;(2):43-55.

PMID:
22272445
40.

Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles).

Kinsinger CR, Apffel J, Baker M, Bian X, Borchers CH, Bradshaw R, Brusniak MY, Chan DW, Deutsch EW, Domon B, Gorman J, Grimm R, Hancock W, Hermjakob H, Horn D, Hunter C, Kolar P, Kraus HJ, Langen H, Linding R, Moritz RL, Omenn GS, Orlando R, Pandey A, Ping P, Rahbar A, Rivers R, Seymour SL, Simpson RJ, Slotta D, Smith RD, Stein SE, Tabb DL, Tagle D, Yates JR 3rd, Rodriguez H.

Proteomics Clin Appl. 2011 Dec;5(11-12):580-9. doi: 10.1002/prca.201100097.

PMID:
22213554
41.

Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles).

Kinsinger CR, Apffel J, Baker M, Bian X, Borchers CH, Bradshaw R, Brusniak MY, Chan DW, Deutsch EW, Domon B, Gorman J, Grimm R, Hancock W, Hermjakob H, Horn D, Hunter C, Kolar P, Kraus HJ, Langen H, Linding R, Moritz RL, Omenn GS, Orlando R, Pandey A, Ping P, Rahbar A, Rivers R, Seymour SL, Simpson RJ, Slotta D, Smith RD, Stein SE, Tabb DL, Tagle D, Yates JR, Rodriguez H.

Proteomics. 2012 Jan;12(1):11-20. doi: 10.1002/pmic.201100562. Epub 2011 Dec 14.

PMID:
22069307
42.

Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles).

Kinsinger CR, Apffel J, Baker M, Bian X, Borchers CH, Bradshaw R, Brusniak MY, Chan DW, Deutsch EW, Domon B, Gorman J, Grimm R, Hancock W, Hermjakob H, Horn D, Hunter C, Kolar P, Kraus HJ, Langen H, Linding R, Moritz RL, Omenn GS, Orlando R, Pandey A, Ping P, Rahbar A, Rivers R, Seymour SL, Simpson RJ, Slotta D, Smith RD, Stein SE, Tabb DL, Tagle D, Yates JR, Rodriguez H.

J Proteome Res. 2012 Feb 3;11(2):1412-9. doi: 10.1021/pr201071t. Epub 2011 Dec 8.

43.

Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles).

Kinsinger CR, Apffel J, Baker M, Bian X, Borchers CH, Bradshaw R, Brusniak MY, Chan DW, Deutsch EW, Domon B, Gorman J, Grimm R, Hancock W, Hermjakob H, Horn D, Hunter C, Kolar P, Kraus HJ, Langen H, Linding R, Moritz RL, Omenn GS, Orlando R, Pandey A, Ping P, Rahbar A, Rivers R, Seymour SL, Simpson RJ, Slotta D, Smith RD, Stein SE, Tabb DL, Tagle D, Yates JR 3rd, Rodriguez H.

Mol Cell Proteomics. 2011 Dec;10(12):O111.015446. doi: 10.1074/mcp.O111.015446. Epub 2011 Nov 3.

44.

The human proteome project: current state and future direction.

Legrain P, Aebersold R, Archakov A, Bairoch A, Bala K, Beretta L, Bergeron J, Borchers CH, Corthals GL, Costello CE, Deutsch EW, Domon B, Hancock W, He F, Hochstrasser D, Marko-Varga G, Salekdeh GH, Sechi S, Snyder M, Srivastava S, Uhlén M, Wu CH, Yamamoto T, Paik YK, Omenn GS.

Mol Cell Proteomics. 2011 Jul;10(7):M111.009993. doi: 10.1074/mcp.M111.009993.

45.

The human proteome project: Current state and future direction.

Legrain P, Aebersold R, Archakov A, Bairoch A, Bala K, Beretta L, Bergeron J, Borchers C, Corthals GL, Costello CE, Deutsch EW, Domon B, Hancock W, He F, Hochstrasser D, Marko-Varga G, Salekdeh GH, Sechi S, Snyder M, Srivastava S, Uhlen M, Hu CH, Yamamoto T, Paik YK, Omenn GS.

Mol Cell Proteomics. 2011 Apr 29. [Epub ahead of print]

46.

Selected reaction monitoring applied to proteomics.

Gallien S, Duriez E, Domon B.

J Mass Spectrom. 2011 Mar;46(3):298-312. doi: 10.1002/jms.1895. Review.

PMID:
21394846
47.

Systematic quantification of peptides/proteins in urine using selected reaction monitoring.

Selevsek N, Matondo M, Sanchez Carbayo M, Aebersold R, Domon B.

Proteomics. 2011 Mar;11(6):1135-47. doi: 10.1002/pmic.201000599. Epub 2011 Feb 16.

PMID:
21360671
48.

Toward a standardized urine proteome analysis methodology.

Court M, Selevsek N, Matondo M, Allory Y, Garin J, Masselon CD, Domon B.

Proteomics. 2011 Mar;11(6):1160-71. doi: 10.1002/pmic.201000566. Epub 2011 Feb 16.

PMID:
21328537
49.

Selected reaction monitoring applied to quantitative proteomics.

Kiyonami R, Domon B.

Methods Mol Biol. 2010;658:155-66. doi: 10.1007/978-1-60761-780-8_9.

PMID:
20839103
50.

Increased selectivity, analytical precision, and throughput in targeted proteomics.

Kiyonami R, Schoen A, Prakash A, Peterman S, Zabrouskov V, Picotti P, Aebersold R, Huhmer A, Domon B.

Mol Cell Proteomics. 2011 Feb;10(2):M110.002931. doi: 10.1074/mcp.M110.002931. Epub 2010 Jul 27.

Supplemental Content

Support Center